Ubiquitin chromatin remodelling after DNA damage is associated with the expression of key cancer genes and pathways-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ubiquitin chromatin remodelling after DNA damage is associated with the expression of key cancer genes and pathways

Published:2020-05-26 Issue:3 Volume:78 Page:1011-1027
ISSN:1420-682X
Container-title:Cellular and Molecular Life Sciences
language:en
Short-container-title:Cell. Mol. Life Sci.

Author:

Cole Alexander J.,Dickson Kristie-Ann,Liddle Christopher,Stirzaker Clare,Shah Jaynish S.,Clifton-Bligh Roderick,Marsh Deborah J.^ORCID

Funder

Cancer Council NSW

Cancer Institute NSW

Australian Research Council

National Health and Medical Research Council

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Cellular and Molecular Neuroscience,Pharmacology,Molecular Biology,Molecular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00018-020-03552-5.pdf

Reference69 articles.

1. Apps MG, Choi EH, Wheate NJ (2015) The state-of-play and future of platinum drugs. Endocr Relat Cancer 22(4):R219–233. https://doi.org/10.1530/erc-15-0237

2. Bowtell DD, Bohm S, Ahmed AA, Aspuria PJ, Bast RC Jr, Beral V, Berek JS, Birrer MJ, Blagden S, Bookman MA, Brenton JD, Chiappinelli KB, Martins FC, Coukos G, Drapkin R, Edmondson R, Fotopoulou C, Gabra H, Galon J, Gourley C, Heong V, Huntsman DG, Iwanicki M, Karlan BY, Kaye A, Lengyel E, Levine DA, Lu KH, McNeish IA, Menon U, Narod SA, Nelson BH, Nephew KP, Pharoah P, Powell DJ Jr, Ramos P, Romero IL, Scott CL, Sood AK, Stronach EA, Balkwill FR (2015) Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer 15(11):668–679. https://doi.org/10.1038/nrc4019

3. Chapman-Rothe N, Curry E, Zeller C, Liber D, Stronach E, Gabra H, Ghaem-Maghami S, Brown R (2013) Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumor-sustaining and chemo-resistant ovarian tumor cells. Oncogene 32(38):4586–4592. https://doi.org/10.1038/onc.2012.477

4. Liu D, Zhang XX, Li MC, Cao CH, Wan DY, Xi BX, Tan JH, Wang J, Yang ZY, Feng XX, Ye F, Chen G, Wu P, Xi L, Wang H, Zhou JF, Feng ZH, Ma D, Gao QL (2018) C/EBPbeta enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation. Nat Commun 9(1):1739. https://doi.org/10.1038/s41467-018-03590-5

5. Long J, Fang WY, Chang L, Gao WH, Shen Y, Jia MY, Zhang YX, Wang Y, Dou HB, Zhang WJ, Zhu J, Liang AB, Li JM, Hu J (2017) Targeting HDAC3, a new partner protein of AKT in the reversal of chemoresistance in acute myeloid leukemia via DNA damage response. Leukemia 31(12):2761–2770. https://doi.org/10.1038/leu.2017.130

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PARP1 modulates METTL3 promoter chromatin accessibility and associated LPAR5 RNA m6A methylation to control cancer cell radiosensitivity;Molecular Therapy;2023-09

2. L3MBTL1, a polycomb protein, promotes Osimertinib Acquired resistance through Epigenetic Regulation of DNA damage response in lung adenocarcinoma;2023-05-18

3. Epigenetic regulation of epithelial–mesenchymal transition during cancer development;Epigenetic Regulation of Cancer - Part A;2023

4. Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis;Frontiers in Cell and Developmental Biology;2022-07-06

5. The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells;Pharmaceutics;2022-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3